Results 271 to 280 of about 173,630 (384)

Prolonged Vancomycin‐Induced Linear IgA Disease in a Patient With Renal Failure

JEADV Clinical Practice, EarlyView.
ABSTRACT A 64‐year‐old man with pneumococcal septic shock and subsequent renal failure underwent treatments with antibiotics including intravenous vancomycin (VCM). Blistering skin lesions appeared 10 days after the initiation of VCM. When the patient was transferred to us 5 months later, blisters with erythema were still observed on the abdomen and ...
Kaori Takezawa, Reiko Noborio, Yuki Nomura, Takahiro Kiyohara, Mako Mine, Takashi Hashimoto   +5 more
wiley   +1 more source

Multi-platform diagnostic strategy and biosecurity as basis of contagious agalactia control programs in endemic areas. [PDF]

Ir Vet J
De la Fe C, Grau A, Minguez O, Sánchez A, Esquivel R, Corrales JC.   +5 more
europepmc   +1 more source

A Case of Anti‐TNFα Therapies Induced Lupus Panniculitis Successfully Improved With a JAK Inhibitor (Baricitinib)

JEADV Clinical Practice, EarlyView.
ABSTRACT Lupus erythematosus panniculitis (LEP) is a rare variant of cutaneous lupus erythematosus (1%–3% of CLE). There are two case reports to date in the literature of LEP potentially triggered by anti‐TNF‐α therapies. Clinically, it is characterised by tender, erythematous subcutaneous indurated nodules or plaques on fatty body areas.
Cristina Grechin, Jane Doheny, Keith Pilson, Donough Howard, Muireann Roche   +4 more
wiley   +1 more source

Management Challenge of Coexistence of Macrophage Activation Syndrome, Systemic Lupus Erythematosus, and Hepatitis B: Case Report. [PDF]

Clin Case Rep
Rakotonirina LN, Andrianiaina MO, Rakotonirainy OH, Ramanandafy H, Randriamifidy NH, Rapelanoro Rabenja F.   +5 more
europepmc   +1 more source

T-cell activation and senescence in asymptomatic HIV/Leishmania infantum co-infection. [PDF]

PLoS Negl Trop Dis
de Oliveira Mendes-Aguiar C, do Monte Alves M, Lopes Machado AA, Monteiro GRG, Marques Medeiros I, Queiroz JW, Lima ID, Costa EG, Pearson RD, Wilson ME, Glesby MJ, do Nascimento ELT, Jerônimo SMB.   +12 more
europepmc   +1 more source

Identifying Cellular Immunodeficiency Through a Persistent Herpetic Whitlow

JEADV Clinical Practice, EarlyView.
ABSTRACT Cutaneous infections caused by HSV are common, with the oral and genital mucosa being most frequently affected (1, 2). In individuals with immunodeficiency, HSV‐2 caused skin lesions may appear severe and unusual, or occur simultaneously with other skin diseases (3).
Chiara L. Blomen, Finn Abeck, Nina Booken, Ute Siemann‐Harms, Stefan W. Schneider   +4 more
wiley   +1 more source

Correction: Comparative analysis of clinical features of brucellosis in Kashi and Guangzhou: a retrospective multicentre study. [PDF]

BMC Infect Dis
Pan S, Chen S, Huang Z, Zhou K, Zeng G, Tuerxun M, Zhu J, Chong Y.   +7 more
europepmc   +1 more source

Treatment of Pyoderma Gangrenosum With Bimekizumab

JEADV Clinical Practice, EarlyView.
ABSTRACT Pyoderma gangrenosum (PG) is an inflammatory neutrophilic dermatosis with no FDA‐approved treatments. Current therapies, including corticosteroids and immunomodulators, often show limited efficacy and nonspecific, conferring to higher risk of adverse events.
Kareena S. Garg, Adeel Ahmad, Leonardo Tjahjono   +2 more
wiley   +1 more source

Can Oral Swabs Be Used to Diagnose Nontuberculous Mycobacterial Cervicofacial Lymphadenitis?

The Laryngoscope, EarlyView.
ABSTRACT Objective We investigated the presence of mycobacteria in the oral cavity and oropharynx of children with nontuberculous mycobacterial (NTM) cervicofacial lymphadenitis compared to negative controls. Our aim was to evaluate whether oral cavity and oropharyngeal swab sampling could serve as a minimally invasive alternative to diagnostic ...
Samuel H. Willemse, Luc H. E. Karssemakers, Marjolijn A. E. M. Oomens, Willem H. Schreuder, Jean‐Pierre T. F. Ho, Marion Kolader, Robin van Houdt, Martijn van der Kuip, Gina R. Buijsers, Jan de Lange, Jerome A. Lindeboom   +10 more
wiley   +1 more source

The T-cell response to SARS-CoV- 2 vaccination persists beyond six months in rheumatoid arthritis patients treated with rituximab. [PDF]

Arthritis Res Ther
Marin J, Bourgoin P, Saverna N, Cartagena C, Lafforgue P, Busnel JM, Balandraud N.   +6 more
europepmc   +1 more source